Articles

A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
Daiichi Sankyo Co, Ltd, Tokyo
Plexxikon Inc., Berkeley, CA
Plexxikon Inc., Berkeley, CA
Plexxikon Inc., Berkeley, CA
Plexxikon Inc., Berkeley, CA
Daiichi Sankyo Co, Ltd, Tokyo
Daiichi Sankyo Co, Ltd, Tokyo
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
Plexxikon Inc., Berkeley, CA
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
Haematologica Early view Jan 28, 2021 https://doi.org/10.3324/haematol.2020.247346